Change - Announcement of Appointment::Appointment of Chief Financial Officer
Issuer & Securities
Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED GRP LTD W190424 - SG5HB3000007 - CSIW
Stapled Security
No
Announcement Details
Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
02-Jul-2018 18:05:28
Status
New
Announcement Sub Title
Appointment of Chief Financial Officer
Announcement Reference
SG180702OTHRXLVS
Submitted By (Co./ Ind. Name)
Hasan Malik
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
In the Company's circular to shareholders dated 28 February 2018 to obtain approval of the Company's very substantial acquisition of Sasteria Pte. Ltd, Mr. Tan Zing Yuen was identified to be appointed as Chief Financial Officer of the Company in place of Mr. Tan Wee Tuck in the interim, until a replacement is found.
Additional Details
Date Of Appointment
01/07/2018
Name Of Person
Tan Zing Yuen
Age
63
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Mr Tan Zing Yuen is eminently qualified to act as CFO of the Company, being the CFO of Thomson Medical Pte Ltd, one of the Company's key subsidiaries. Mr Tan has led the finance function of the Thomson Medical Group effectively for almost a decade. Mr Tan's appointment allows Mr Tan Wee Tuck to concentrate on leadership of the real estate business of the Company as CEO Real Estate.
Whether appointment is executive, and if so, the area of responsibility
Mr Tan is appointed in an executive capacity, and he will lead the finance function of the whole Thomson Medical Group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
Mr Tan Zing Yuen is the Chief Financial Officer of Thomson Medical Pte Ltd. Mr Tan joined Thomson Medical in September 2009 as Chief Financial Officer. From 2006 to 2009, Mr Tan was the Group Financial Controller in the MediaCorp Group. From 2002 to 2006, Mr Tan was the Chief Financial Officer of Energy Market Company Pte Ltd. Prior to this, Mr Tan has held key financial positions in several public-listed companies, namely, as Finance Director in Courts Singapore Limited and as Chief Financial Officer of Nippecraft Limited Group and Flairis Technology Corporation Limited Group. Mr Tan holds a Bachelor of Accountancy Degree from University of Singapore (now known as the National University of Singapore) and is a member of the Institute of Singapore Chartered Accountants.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
50,000 shares and 100,000 warrants in the Issuer
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Please see attached
Present
Please see attached
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of a listed company?
No
If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed company
Not being appointed as a director of the Issuer
Attachments
TZY Current Directorships.pdf
TZY Past Directorships.pdf
Total size =73K
Related Announcements
Related Announcements